WallStSmart
NUTX

Nutex Health Inc

NASDAQ: NUTX · HEALTHCARE · MEDICAL CARE FACILITIES

$119.20
+6.41% today

Updated 2026-04-30

Market cap
$772.02M
P/E ratio
10.57
P/S ratio
0.88x
EPS (TTM)
$10.48
Dividend yield
52W range
$77 – $193
Volume
0.2M

Nutex Health Inc (NUTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+27.5%
Last 4 quarters
Revenue YoY growth
-41.1%
Most recent quarter
EPS YoY growth
-85.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+7.9%
2025-11-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-06$1.62-70.8%$105.34$98.61-6.4%
2025-11-18$-2.95-251.3%$103.95$112.19+7.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$5.56$1.62-70.8%$151.68M-41.1%
2025-09-30$1.95$-2.95-251.3%$267.80M+239.9%
2025-06-30$-5.43$5.23+196.2%$243.99M+220.7%
2025-03-31$3.91$11.12+184.8%$211.79M+214.0%
2024-12-31$-0.12$11.12+9118.7%$257.62M+269.8%
2024-09-30$-0.24$-1.72-616.7%$78.79M+25.6%
2024-06-30$-0.29$-0.07+75.9%$76.08M+29.1%
2024-03-31$-0.06$67.45M+19.7%
2023-12-31$-0.01$-0.05-834.0%$69.67M
2023-09-30$-0.01$-0.01-100.0%$62.72M
2023-06-30$-0.01$-0.01+0.0%$58.92M
2023-03-31$-0.01$-0.01+0.0%$56.33M

Frequently asked questions

Has Nutex Health Inc beaten earnings estimates?
Nutex Health Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +27.5% over the last 4 quarters.
How does NUTX stock react to earnings?
NUTX stock has moved an average of +0.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Nutex Health Inc's revenue growth rate?
Nutex Health Inc reported year-over-year revenue growth of -41.1% in its most recent quarter, with EPS growing -85.4% year-over-year.